𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clonazepam use in pregnancy and the risk of malformations

✍ Scribed by Angela E. Lin; Allyson J. Peller; Marie-Noel Westgate; Kara Houde; Aleda Franz; Lewis B. Holmes

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
62 KB
Volume
70
Category
Article
ISSN
1542-0752

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND

Clonazepam (Klonopin) is a benzodiazepine that has been used widely to treat seizures and conditions such as panic attacks and anxiety disorder. However, the current findings about its use in pregnancy are derived from limited studies of small sample size. Because it is commonly prescribed during pregnancy, more information about its safety is needed.

METHODS

The medical records of 28,565 infants were surveyed as part of a hospital‐based malformation surveillance program to identify those who had been exposed prenatally to an anticonvulsant, including clonazepam.

RESULTS

During a 32‐month period, 166 anticonvulsant‐exposed infants were identified; 52 had been exposed to clonazepam, 43 as monotherapy. A total of 33 (76.7%) of the monotherapy infants were exposed during the first trimester. One (3.0%) infant had dysmorphic features, growth retardation, and a heart malformation (tetralogy of Fallot).

CONCLUSIONS

This study did not observe an increase in major malformations in births exposed to clonazepam monotherapy. However, this study is not large enough to have adequate power to determine whether or not the rate of major malformations is increased in clonazepam‐exposed pregnancies. No increase has been identified in three other case series. Although the number of patients in this series was larger than previous reports, continued monitoring of pregnancies is needed to determine whether or not clonazepam is teratogenic. Birth Defects Research (Part A), 2004. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Beta2-agonists use during pregnancy and
Beta2-agonists use during pregnancy and the risk of congenital malformations
✍ Sherif Eltonsy; Amélie Forget; Lucie Blais 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

## Abstract ## BACKGROUND Treatment of asthma symptoms during pregnancy is crucial for maternal and fetal health. Short‐acting beta~2~‐agonists (SABA) are frequently used as rescue medications and long‐acting beta~2~‐agonists (LABA) are used as add‐on controller therapy for asthma during pregnancy

Use of antihistamine medications during
Use of antihistamine medications during early pregnancy and isolated major malformations
✍ Suzanne M. Gilboa; Matthew J. Strickland; Andrew F. Olshan; Martha M. Werler; Ad 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## BACKGROUND: Antihistamines are commonly used during pregnancy. There is little evidence that they have teratogenic effects, but there are knowledge gaps with respect to newer products, as well as the relationship between specific antihistamines and specific birth defects. ## METHOD

Antihypertensive medication use during p
Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns
✍ H. R. Nakhai-Pour; E. Rey; A. Bérard 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

## Abstract **BACKGROUND:** In spite of the widespread use of antihypertensives during pregnancy, data on their risks and benefits for the newborn are limited. We investigated the risk of major congenital malformations or small‐for‐gestational‐age newborns (SGA) in relation to gestational use of an

Maternal use of selective serotonin re-u
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations
✍ Bengt A. J. Källén; Petra Otterblad Olausson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

## Abstract ## BACKGROUND: Maternal use of selective serotonin re‐uptake inhibitors (SSRIs) has recently been associated with an increased risk for certain malformations. ## METHODS: Using the Swedish Medical Birth Register, we identified women who had reported the use of SSRIs in early pregnanc